During the past decade, Vital Medical Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 16 clinical trials were completed, i.e. on average, 64% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 14 clinical trials were completed. i.e. 107.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vital Medical Center" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Pfizer" with 6 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Fresenius Kabi SwissBioSim GmbH" with 2 trials sponsored and "R-Pharm International, LLC" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vital Medical Center" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "Mene Research" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Vital Medical Center" are "Rheumatoid Arthritis" (11 trials), "Arthritis, Psoriatic" (4 trials), "Psoriatic Arthritis" (3 trials), "Systemic Lupus Erythematosus" (2 trials) and "Ankylosing Spondylitis" (1 trials). Many other conditions were trialed in "Vital Medical Center" in a lesser frequency.

Most popular intervention types in "Vital Medical Center" are "Drug" (21 trials), "Biological" (4 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Baricitinib" (3 trials), "Guselkumab" (3 trials), "Tofacitinib" (3 trials) and "Adalimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vital Medical Center" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Vital Medical Center". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Vital Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Vital Medical Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".